EUVIMEDEUVIMED entdecken
Crossref

Inhibitors of Gut Bacterial l -Dopa Decarboxylation with Reduced Susceptibility to Host Metabolism

Rohan Narayan iD, Chi Chip Le iD, Jai K Khurana iD, Vincent Nieto, Christine A Olson iD, Peter J Turnbaugh, Emily P Balskus iD

ACS Chemical Biology · 18.11.2026

DOI: 10.1021/acschembio.6c00480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 18.11.2026. Verfasst von Rohan Narayan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts02138, United States. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Jane Coffin Childs Memorial Fund for Medical Research, Biocodex Microbiota Foundation, Blavatnik Biomedical Accelerator, Harvard University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microorganisms in the human gut influence the efficacy and metabolism of host-targeted small molecule therapeutics, including the frontline Parkinson’s disease drug levodopa (l-dopa). Previous work has identified a mechanism-based inhibitor of gut bacterial decarboxylases that degrade l-dopa, α-fluoromethyltyrosine (AFMT). However, early experiments with AFMT in rodent models suggested undesirable in vivo metabolism by host tyrosine hydroxylase, producing α-fluoromethyldopa, a metabolite likely to worsen Parkinson’s phenotypes and prevent application as an l-dopa cotreatment. Here, we demonstrate oxidation of AFMT to α-fluoromethyldopa in vitro by recombinant human tyrosine hydroxylase. We then develop AFMT analogues that retain activity against bacterial decarboxylases but have reduced susceptibility to host hydroxylation. Suitable arenes for inhibitor design were identified using assays with commercially available noncanonical amino acids, which revealed aryl difluorination as a promising modification. Difluoroaryl AFMT derivatives are less prone to degradation by tyrosine hydroxylase in vitro yet still inhibit l-dopa metabolism by bacterial decarboxylases. This work exemplifies how substrate reactivity can streamline design of mechanism-based enzyme inhibitors, as well as how constraints posed by the host can be incorporated during development of microbiome-targeted therapeutics. The compounds reported here are promising starting points for future studies in animal models and further exploration of gut bacterial effects on l-dopa treatment efficacy.

Autor:innen und Institutionen

  • Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts02138, United States.
  • Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California94143, United States.
  • Biohub , San Francisco, San Francisco, California94158, United States.
  • Howard Hughes Medical Institute, Harvard University, Cambridge, Massachusetts02138, United States.

ORCID-Profile: Rohan Narayan, Chi Chip Le, Jai K Khurana, Christine A Olson, Emily P Balskus

Förderung

  • Jane Coffin Childs Memorial Fund for Medical Research
  • Biocodex Microbiota Foundation
  • Blavatnik Biomedical Accelerator, Harvard University

Zitieren

APA

Narayan, R., Le, C. C., Khurana, J. K., Nieto, V., Olson, C. A., Turnbaugh, P. J., & Balskus, E. P. (2026). Inhibitors of Gut Bacterial l -Dopa Decarboxylation with Reduced Susceptibility to Host Metabolism. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00480

Vancouver

Narayan R, Le CC, Khurana JK, Nieto V, Olson CA, Turnbaugh PJ, et al. Inhibitors of Gut Bacterial l -Dopa Decarboxylation with Reduced Susceptibility to Host Metabolism. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00480

BibTeX
@article{Narayan2026,
  author = {Narayan, Rohan and Le, Chi Chip and Khurana, Jai K and Nieto, Vincent and Olson, Christine A and Turnbaugh, Peter J and Balskus, Emily P},
  title = {Inhibitors of Gut Bacterial l -Dopa Decarboxylation with Reduced Susceptibility to Host Metabolism},
  journal = {ACS Chemical Biology},
  year = {2026},
  doi = {10.1021/acschembio.6c00480}
}
Kostenlos starten →